作者: Patama Pongsuwan
DOI: 10.1007/978-1-60327-256-8_12
关键词: Metformin 、 Type 2 Diabetes Mellitus 、 Insulin 、 Type 2 diabetes 、 Pharmacology 、 Thiazolidinedione 、 Sulfonylurea 、 Obesity 、 Medicine 、 PPAR agonist
摘要: Few pharmacologic agents commonly used to manage pediatric obesity and type 2 diabetes mellitus (T2DM) have been studied rigorously in populations. Although not the mainstay of prevention risk reduction, proven effective treating acute sequelae T2DM.